BREAKING
Josephine Chen speaking at TechCrunch Disrupt 2022

Partner, Sequoia Capital

Josephine
Chen

The Bridge Builder Who Won't Pick a Lane

"The best conversations are the ones that continue to 4AM because we are riffing on each other's ideas."

Seed Stage Series A Enterprise Fintech Crypto Healthtech
10+ Portfolio Companies
2 Stripe Acquisitions
2019 Joined Sequoia
$5M Sweet Spot Check

Seven Schools. One Relentless Standard.

The first thing you notice about Josephine Chen's career arc is that she refused to be categorized. Sequoia needed someone who could hold enterprise software, fintech, and crypto in the same hand without dropping any of them. Chen had been quietly making herself into exactly that person since middle school, when she walked into an immunology lab and didn't leave for years.

Born in Massachusetts, raised mostly in Taiwan, relocated to the Bay Area at age ten - she attended seven different schools growing up. That is not a detail to skip past. Seven schools means seven first days, seven new social graphs to decode, seven sets of unspoken rules. It produces either someone who shuts down or someone who becomes fluent in rooms where everything is unfamiliar. Chen became the latter.

Her parents built a business from scratch in a country where, as Chen puts it, "everything was foreign to them" - while simultaneously raising two daughters. That particular kind of tenacity - building something real without a safety net, in a language you're still learning, in a culture that wasn't built for you - became Chen's baseline. It's why she finds immigrant founders not just appealing but almost obvious. She's seen the model work.

From the Lab to the Board Room

At Stanford, she chose Biomedical Informatics - a degree that forces you to be fluent in biology, statistics, and computer science simultaneously, which is its own version of adapting to seven new schools. She wasn't just studying the subject; she was already inside it. Research stints at Genentech (translational oncology), Stanford School of Medicine, UC Davis, and the Stanford Center for Clinical Research meant she was doing actual science, not just coursework. One project: studying a protein target with potential to slow Alzheimer's.

Then came McKinsey - the kind of training that teaches you to walk into any room, understand the incentive structure in thirty minutes, and start asking the questions nobody else asked. Then Emergence Capital, one of the few firms that made enterprise SaaS its identity before enterprise SaaS was a phrase anyone outside the industry would use. By the time Sequoia called in 2019, Chen had assembled a portfolio of experiences that didn't fit a single category. That was the point.

"Finding true product market fit is indistinguishable from magic - I'm inspired by founders who pursue it relentlessly."
- Josephine Chen, Partner, Sequoia Capital

The Bridge Nobody Else Is Building

Chen's investment thesis sits at an unusual intersection: enterprise software, fintech, and crypto. Not as three separate buckets, but as one continuous opportunity where the walls between categories are dissolving. She's described herself as "a bridge" across these domains - which sounds like a nice metaphor until you realize that most investors in each of these areas see the other two as distractions. Chen sees them as the same story told three ways.

Her healthcare angle is even more specific. She thinks the biggest software opportunities of this century will come from biology meeting computer science - not in a vague AI-will-fix-healthcare way, but through the concrete mechanics of value-based care, patient data accessibility, and digital care delivery. She was doing biology-plus-computation before it was a venture thesis. That's not a coincidence.

On the enterprise side, her bet is on vertical SaaS players who go deep into legacy industries and unlock the insights buried in their data. Healthcare is the obvious example, but the pattern applies anywhere that old industries are still running on spreadsheets and phone calls. The founders who know these industries from the inside - who worked the floor, felt the friction - are the ones she wants to back.

What She's Actually Looking For

Chen is unusually direct about her process. She doesn't want founders to pitch her; she wants to riff with them. "It's never too early to come talk with us," she's said. The pitch call that ends when someone has to catch a flight is not what she's after. She is after the conversation that nobody planned to have, that started as one thing and became something else entirely because both people kept following the idea. "Discussing ideas and riffing on them is my favorite part of this job."

What she looks for in founders: genuine market expertise (not studied expertise, but lived expertise), the combination of strategic thinking and execution ability, and the ability to articulate not just what they're building but why this problem has gone unsolved. Her questioning style in pitch meetings is probing but not adversarial. She's trying to understand how a founder thinks, not whether they can withstand pressure.

The personal quirks are telling. She trades DeFi in her own accounts - not as a hedge, but because she's genuinely curious about how it works in practice. She's a musical theater enthusiast. She explores new cultures through food. These are the habits of someone who finds the world interesting in a non-performative way, which is exactly the quality she seems to value most in the founders she backs.

"I love partnering at the earliest stages because I get to dream of the future with founders while also tackling the day-to-day operations."
- Josephine Chen, Sequoia Capital

The Portfolio Tells the Story

Look at what she's backed and a pattern emerges. Found helps self-employed people and freelancers manage their finances - the overlooked small business layer that fintech largely ignored. AMP Robotics applies AI to recycling, a real-world industrial problem with significant scale. Anrok solves sales tax compliance for software companies - not glamorous, but deeply necessary. Cresta brings AI to contact centers. Abby Care gets family caregivers paid. Freed automates medical documentation for clinicians. Magic Eden is one of the dominant NFT marketplaces.

The thread: real problems, often in industries that have been underserved by software, with founders who understand the problem from the inside. Bridge and Privy - both acquired by Stripe - validated the thesis in fintech. When two of your early bets get absorbed by one of the most credible companies in payments, it suggests you found something real.

Chen joined Alfred Lin in writing Sequoia's announcement of the Found investment, describing co-founder Lauren Myrick's background - former accountant, Square executive - as exactly the kind of inside knowledge that makes a fintech founder dangerous in the best way. That attentiveness to founder background, to the specific experience that makes someone uniquely positioned to solve a problem, shows up repeatedly in who she backs.

On Immigrant Founders

Chen speaks about immigrant founders with a directness that suggests lived experience rather than portfolio strategy. "I strongly believe in immigrant founders," she has said. "I saw firsthand the sheer tenacity of my parents who built a business while raising two daughters in a country where everything was foreign to them." This is not a talking point. It's a formative fact, repeated because it's true, and because it explains something real about what she thinks makes a founder likely to succeed when things get hard.

The century's most interesting technology is going to be built at the intersection of things that weren't supposed to intersect: biology and computer science, traditional industries and modern software, finance and crypto infrastructure. The investors who can hold multiple frames simultaneously - who don't need to pick a lane because they've been navigating new terrain since age ten - are the ones most likely to see those intersections early. Chen has been practicing for this role for a long time.

Three Pillars. One Aperture.

01

Biology x Code

The century's greatest innovations will come from where biology meets computer science. Value-based care, patient data, digital health - Chen started tracking this intersection as a researcher, not just an investor.

02

Vertical SaaS

Old industries running on legacy processes have decades of compressed opportunity. The founders who know these industries from the inside - who felt the friction firsthand - are who she wants to back.

03

The Bridge

Enterprise software, fintech, and crypto are converging. Rather than specializing in one, Chen positions herself where the categories blur - because that's where the next defining companies are being built.

Companies She's Backed

Found

Fintech

Financial tools for self-employed workers and freelancers

Board Observer

AMP Robotics

AI / Robotics

AI-powered sortation to modernize recycling operations

Board Observer

Anrok

Fintech / Tax

Sales tax compliance platform built for software companies

Cresta

AI / Enterprise

AI intelligence for contact centers and customer service

Abby Care

Healthtech

Helps family caregivers get paid and supported

Board Director

Freed

AI / Health

AI medical scribe that automates clinical documentation

Board Director

Magic Eden

Crypto / NFT

Multi-chain NFT marketplace and digital collectibles platform

Nuvo

Fintech

B2B trade credit and payments infrastructure

Crosby

AI / Legal

AI-powered law firm model launched 2025

Bridge

Fintech / Crypto

Stablecoin payments infrastructure

Acquired by Stripe

Privy

Crypto / Web3

Auth and wallet infrastructure for Web3 apps

Acquired by Stripe

Benchling

Biotech / SaaS

R&D cloud platform for life sciences

What Josephine Chen Actually Says

"I strongly believe in immigrant founders: I saw firsthand the sheer tenacity of my parents who built a business while raising two daughters in a country where everything was foreign to them."

"This will be the century where some of the greatest innovations come at the intersection of biology and computer science."

"It's never too early to come talk with us. Discussing ideas and riffing on them is my favorite part of this job."

"I think there's still tremendous opportunity in classic, vertical SaaS for entrepreneurs to bring the future forward in traditional industries like healthcare."

"I love partnering at the earliest stages because I get to dream of the future with founders while also tackling the day-to-day operations."

"Finding true product market fit is indistinguishable from magic - I'm inspired by founders who pursue it relentlessly."

Beyond the Portfolio

🔬

Started doing immunology research in middle school - years before most students know the word exists.

🎭

Musical theater enthusiast - a passion that coexists happily with biomedical informatics and DeFi.

Personally trades DeFi as a hobby - real skin-in-the-game before backing crypto companies like Magic Eden.

Attended seven different schools growing up across Massachusetts, Taiwan, and the Bay Area - moved to the US at age ten.

🍜

Explores cultures through cuisine - a natural continuation of growing up across three very different places.

💳

Two portfolio companies - Bridge and Privy - were both acquired by Stripe, making her one of Stripe's most reliable talent scouts.

venture capital sequoia capital enterprise software fintech crypto seed stage series a healthtech biomedical stanford mckinsey vertical saas digital health immigrant founders san francisco biology x code web3 consumer internet early stage board director